Brand Reference: Rozerem
| Metric | Verified Benchmark | Source |
|---|---|---|
| Ramelteon RxNorm Concept ID | 577057 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.6200 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $245.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $14.90 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $18.00 / mo | 18 Zero-PHI Verified Patient Logs |
Binds suprachiasmatic nucleus MT1 receptors (6x higher affinity than endogenous melatonin, silencing evening SCN wake firing) and MT2 receptors (8x affinity, phase-advancing delayed circadian clocks) with zero affinity for MT3, GABA, opioid, or dopamine sites—completely unscheduled.
Across 18 community cost disclosures for Ramelteon (Rozerem), cash buyers routing around $245.00 retail markups capture a 94% discount ($14.90/mo benchmark vs $0.6200 NADAC acquisition).
Following administration (8 mg PO 30 minutes prior to target sleep onset), Ramelteon achieves 1.8% oral (avoid high-fat meal right before dose) bioavailability and 30 minutes sleep-onset phase advance onset, governed by a 1–2.6 hours parent / 2–5 hours active M-II metabolite terminal half-life through hepatic cyp1a2 (major—contraindicated with fluvoxamine), cyp2c19, cyp3a4.
Before initiating Ramelteon at 8 mg PO 30 minutes prior to target sleep onset, clinical safety checklists rule out concomitant fluvoxamine (increases ramelteon auc 190-fold!); severe child-pugh c liver disease. Logged tolerability patterns center on vivid early-cycle dreams (13% of reports), mild dizziness (6% of reports).
Across 18 verified cash-pay logs, Ramelteon achieves a 80.90% Worth-It rating with out-of-pocket spend averaging $18.00/mo versus $245.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Cost Plus Drugs at 8 mg PO 30 minutes prior to target sleep onset for Ramelteon; monthly out-of-pocket dropped to $13.11 compared with $245.00 retail.
Completed 10 weeks on Ramelteon (8 mg PO 30 minutes prior to target sleep onset). Zero notable side effects on steady dosing.
Consistent biomarker response on 8 mg PO 30 minutes prior to target sleep onset Ramelteon sourced via Cash Clinic ($17.28/mo cash pay without insurance prior authorization).